Header cover image

U.K. (FTSE) Healthtech Industry Analysis

UpdatedJun 05, 2023
DataAggregated Company Financials
Companies11
  • 7D2.2%
  • 3M-19.3%
  • 1Y-5.8%
  • YTD-21.7%

In the last week, the Healthtech industry is up 2.2%, with Craneware up 12%. However, the industry is down 5.8% over the past year. Looking forward, earnings are forecast to grow by 12% annually.

Industry Valuation and Performance

Has the U.K. Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 06 Jun 2023UKĀ£1.7bUKĀ£415.2m-UKĀ£38,932,370.0051.7x-43.7x4.1x
Thu, 04 May 2023UKĀ£1.9bUKĀ£405.7m-UKĀ£46,460,199.0074.2x-40.6x4.7x
Sat, 01 Apr 2023UKĀ£1.7bUKĀ£407.8m-UKĀ£46,703,295.0065.7x-36.2x4.1x
Mon, 27 Feb 2023UKĀ£2.1bUKĀ£408.4m-UKĀ£48,842,653.0071.6x-43.3x5.2x
Wed, 25 Jan 2023UKĀ£2.1bUKĀ£403.7m-UKĀ£47,568,404.0071x-43.2x5.1x
Fri, 23 Dec 2022UKĀ£2.2bUKĀ£407.0m-UKĀ£48,308,729.0082.8x-44.6x5.3x
Sun, 20 Nov 2022UKĀ£2.3bUKĀ£403.0m-UKĀ£50,224,414.0087.3x-44.9x5.6x
Tue, 18 Oct 2022UKĀ£2.1bUKĀ£411.5m-UKĀ£56,274,159.0069.8x-36.8x5x
Thu, 15 Sep 2022UKĀ£2.2bUKĀ£352.4m-UKĀ£54,519,624.0084.6x-39.6x6.1x
Sat, 13 Aug 2022UKĀ£2.2bUKĀ£345.4m-UKĀ£53,762,804.0080.7x-40.3x6.3x
Mon, 11 Jul 2022UKĀ£2.2bUKĀ£346.1m-UKĀ£54,011,063.0076.8x-40x6.2x
Wed, 08 Jun 2022UKĀ£1.8bUKĀ£341.6m-UKĀ£47,565,376.0079.3x-38.1x5.3x
Fri, 06 May 2022UKĀ£1.9bUKĀ£343.5m-UKĀ£48,095,234.0083.8x-39.3x5.5x
Sun, 03 Apr 2022UKĀ£2.0bUKĀ£322.5m-UKĀ£46,763,032.0091x-42.3x6.1x
Tue, 01 Mar 2022UKĀ£2.0bUKĀ£285.2m-UKĀ£38,983,477.0077.9x-51.4x7x
Thu, 27 Jan 2022UKĀ£2.3bUKĀ£286.1m-UKĀ£31,193,117.0093.1x-74.7x8.1x
Sat, 25 Dec 2021UKĀ£2.6bUKĀ£286.5m-UKĀ£31,341,348.00100.6x-83.8x9.2x
Mon, 22 Nov 2021UKĀ£2.8bUKĀ£281.9m-UKĀ£26,295,713.00100.7x-104.9x9.8x
Wed, 20 Oct 2021UKĀ£2.9bUKĀ£280.2m-UKĀ£20,099,368.0098.5x-142.3x10.2x
Fri, 17 Sep 2021UKĀ£2.8bUKĀ£265.8m-UKĀ£11,982,353.0067.6x-235.7x10.6x
Sun, 15 Aug 2021UKĀ£3.0bUKĀ£266.2m-UKĀ£11,868,606.4865.6x-253.5x11.3x
Thu, 10 Jun 2021UKĀ£2.8bUKĀ£262.9m-UKĀ£11,200,303.4849.7x-247.2x10.5x
Wed, 03 Mar 2021UKĀ£2.3bUKĀ£259.1m-UKĀ£5,185,482.4043.6x-447.1x8.9x
Sat, 05 Dec 2020UKĀ£2.0bUKĀ£259.8m-UKĀ£5,585,994.7544.1x-349.4x7.5x
Tue, 08 Sep 2020UKĀ£1.8bUKĀ£258.9m-UKĀ£2,344,079.9633.6x-767.6x6.9x
Price to Earnings Ratio

-5089.8x


Total Market Cap: UKĀ£1.7bTotal Earnings: -UKĀ£326,579.96Total Revenue: UKĀ£258.0mTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthtech Industry Price to Earnings3Y Average -335.6x202120222023
Current Industry PE
  • Investors are pessimistic on the British Health Care Technology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 7.8x is higher than the industry's current PS ratio of 4.1x.
Past Earnings Growth
  • The earnings for companies in the Health Care Technology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 17% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does U.K. Healthtech compare with similar industries?

GB Market0.061%
Healthcare-0.45%
Healthtech2.17%
Healthtech2.17%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CRW CranewareUKĀ£14.9012.0%
+UKĀ£55.6m
10.4%PE75.2x
EMIS EMIS GroupUKĀ£13.762.2%
+UKĀ£18.9m
3.5%PE26.2x
IUG Intelligent Ultrasound GroupUKĀ£0.126.7%
+UKĀ£2.5m
-15.8%PS3.9x
RENX RenalytixUKĀ£0.882.9%
+UKĀ£2.3m
-45.3%PS26.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

RENX

UKĀ£0.88

Renalytix

7D

2.9%

1Y

-45.3%

INS

UKĀ£6.30

Instem

7D

-1.6%

1Y

-15.4%

EMIS

UKĀ£13.76

EMIS Group

7D

2.2%

1Y

3.5%

CRW

UKĀ£14.90

Craneware

7D

12.0%

1Y

10.4%

FDBK

UKĀ£1.15

Feedback

7D

-2.1%

1Y

-28.1%